Cas 1134061-62-3,6-fluoro-4-hydroxy-7-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}quinoline-3-carboxylic acid

1134061-62-3

Post Buying Request

Basic information

Product Name: 6-fluoro-4-hydroxy-7-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}quinoline-3-carboxylic acid
Synonyms: 6-fluoro-4-hydroxy-7-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}quinoline-3-carboxylic acid
CAS NO:1134061-62-3
Molecular Formula:
Molecular Weight: 435.378
EINECS: N/A
Product Categories: N/A
Mol File: 1134061-62-3.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 6-fluoro-4-hydroxy-7-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}quinoline-3-carboxylic acid(CAS DataBase Reference)
NIST Chemistry Reference: 6-fluoro-4-hydroxy-7-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}quinoline-3-carboxylic acid(1134061-62-3)
EPA Substance Registry System: 6-fluoro-4-hydroxy-7-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}quinoline-3-carboxylic acid(1134061-62-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1134061-62-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1134061-62-3 Suppliers

Recommended suppliersmore

1134061-62-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1134061-62-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,3,4,0,6 and 1 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1134061-62:
(9*1)+(8*1)+(7*3)+(6*4)+(5*0)+(4*6)+(3*1)+(2*6)+(1*2)=103
103 % 10 = 3
So 1134061-62-3 is a valid CAS Registry Number.

1134061-62-3Upstream product

1134061-62-3Downstream Products

1134061-62-3Relevant articles and documents

Studies on anti-HIV quinolones: New insights on the C-6 position

Massari, Serena,Daelemans, Dirk,Manfroni, Giuseppe,Sabatini, Stefano,Tabarrini, Oriana,Pannecouque, Christophe,Cecchetti, Violetta

experimental part, p. 667 - 674 (2009/08/08)

The 6-desfluoroquinolones which have been developed by our group represent a promising class of compounds for the treatment of HIV infection since they act on transcriptional regulation, a crucial step in the replication cycle that has not been clinically

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1134061-62-3